surmount-1 tirzepatide 15 mg weight loss percent as Compared with Semaglutide for the Treatment of Obesity Shifts in body mass index

December 17th, 2024: Danish studies link Ozempic to doubled risk of rare vision loss condition Novo Nordisks Ozempic is facing scrutiny after two Danish studies found a potential link between the diabetes drug and an increased risk of non-arteritic anterior ischemic optic neuropathy (NAION), a rare condition causing vision loss due to reduced blood flow to the optic nerve

That thinness is great for painless injections, but it makes drawing trickier than most beginners expect

This multidistrict lawsuit has many plaintiffs who allege their gastrointestinal disorders, blood clots, and vision loss was caused by using Trulicity and other GLP-1 drugs

Other gastrointestinal effects include bloating , sulfur burps , and occasional diarrhea